New Wave Of Cancer Drugs Puts Hard Focus On Need For Inexpensive Screening
This article was originally published in PharmAsia News
Executive Summary
Stunning advances in cancer therapies have sharpened the need for low-cost gene sequencing to identify the right patients for the right drugs, especially in Asia, frontline cancer experts say.